Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Johnson & Johnson to pay $2.2 bln to end U.S. probes -source
Reuters
Mon, 11/4/13 - 11:47 am
Tags:
kickbacks, JNJ, Natrecor, off-label, Risperdal
Gilead Sciences and Johnson & Johnson Push Vertex Out of Hepatitis C Race
Motley Fool
Sun, 11/3/13 - 12:06 pm
Tags:
Gilead Sciences, JNJ, Vertex Pharmaceuticals, hepatitis, hepatitis B
This Week in Biotech: Twitter Edition
Motley Fool
Sat, 11/2/13 - 11:36 am
Tags:
Gilead Sciences, PDL Biopharma, Depomed, Vertex Pharmaceuticals, JNJ, Sarepta Therapeutics
When Japanese Pharma Report, These American Biotechs React
Motley Fool
Sat, 11/2/13 - 11:22 am
Tags:
Arena Pharmaceuticals, Medivation, JNJ, Vivus, Astellas, Eisai
Cheaper By The Dozen? J&J Is Sued Over 340B Drug Discounts
Pharmalot
Fri, 11/1/13 - 09:51 am
Tags:
JNJ, 340B, drug discounts
J&J's Janssen Must Pay $4 Million Over Topamax, Jury Says
Bloomberg
Wed, 10/30/13 - 08:45 pm
Tags:
Topamax, JNJ
Why Gilead's Sofosbuvir Is Better Than J&J's Simeprevir
Motley Fool
Tue, 10/29/13 - 09:21 am
Tags:
Gilead, sofosbuvir, JNJ, hepatitis C, simeprevir
J&J Is Curiously Absent From Twitter -- Does That Matter?
Advertising Age
Mon, 10/28/13 - 09:31 am
Tags:
JNJ, twitter, social media
J&J-Medivir Hepatitis C Pills Wins U.S. Panel Backing
Bloomberg
Thu, 10/24/13 - 06:04 pm
Tags:
FDA, JNJ, Medivir, hepatitis C, simeprevir
Diabetes Giants Battle Outside of Their Usual Arena
Motley Fool
Thu, 10/24/13 - 11:29 am
Tags:
Novo Nordisk, diabetes, Merck, Sanofi, NovoSeven, JNJ
Bristol-Myers Squibb - There Is Life After Plavix
Seeking Alpha
Thu, 10/24/13 - 10:19 am
Tags:
Plavix, Bristol-Myers Squibb, JNJ, PFE
Johnson & Johnson's Hidden Source Of Value
Seeking Alpha
Wed, 10/23/13 - 06:31 pm
Tags:
JNJ
J&J-Medivir’s Drug Works Against Hepatitis C
Bloomberg
Tue, 10/22/13 - 08:36 am
Tags:
JNJ, Medivir, hepatitis C, simeprevir, FDA
The 3 Best-Selling Drugs in the World
Motley Fool
Mon, 10/21/13 - 08:24 am
Tags:
AbbVie, Humira, Remicade, JNJ, GSK, Advair
Johnson & Johnson Continues To Ride The Success Of Its Immunology And Oncology Drugs
Seeking Alpha
Fri, 10/18/13 - 10:07 am
Tags:
JNJ, Remicade, Simponi, Stelara, Invokana
Cleveland Clinic picks top 3 blockbuster drug candidates in the late-stage pipeline
Fierce Biotech
Thu, 10/17/13 - 06:18 pm
Tags:
Cleveland Clinic, JNJ, Pharmacyclics, Novartis, serelaxin, ibrutinib, sofosbuvir, Gilead
Can The First Malaria Vaccine Drive GlaxoSmithKline's Growth?
Seeking Alpha
Wed, 10/16/13 - 08:35 am
Tags:
GSK, vaccines, malaria, Agenus, Daiichi Sankyo, RTS,S, JNJ
Janssen's Topamax Users Blame Drug for Birth Defects
Bloomberg
Tue, 10/15/13 - 04:58 pm
Tags:
Janssen, Topamax, JNJ, birth defects
3 Ways Q3 Results Show How J&J Is Dramatically Changing
Motley Fool
Tue, 10/15/13 - 04:57 pm
Tags:
JNJ, earnings
Johnson & Johnson Profit Beats Estimates on Drug Sales
Bloomberg
Tue, 10/15/13 - 08:37 am
Tags:
earnings, JNJ

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.